Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an adjunct to Behavior Modification: The COR-BMOD Trial

This 56-week, randomized, placebo-controlled trial examined the efficacy and safety of naltrexone plus bupropion as an adjunct to intensive behavior modification (BMOD). A total of 793 participants (BMI = 36.5 ± 4.2 kg/m(2)) was randomly assigned in a 1:3 ratio to: (i) placebo + BMOD (N = 202); or (...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Obesity (Silver Spring)
Huvudupphovsmän: Wadden, Thomas A., Foreyt, John P., Foster, Gary D., Hill, James O., Klein, Samuel, O’Neil, Patrick M., Perri, Michael G., Pi-Sunyer, F. Xavier, Rock, Cheryl L., Erickson, Janelle S., Maier, Holly N., Kim, Dennis D., Dunayevich, Eduardo
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2010
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4459776/
https://ncbi.nlm.nih.gov/pubmed/20559296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oby.2010.147
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk